Clinical Trial Update: A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluating duloxetine for atypical depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Depression

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Atypical Depression | Phase 4 | Status: COMPLETED